Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
Lisa Andriani, Yun-Xiao Ling, Shao‐Ying Yang, Qian Zhao, Xiao-Yan Ma, Min-Ying Huang, Yin-Ling Zhang, Fang-Lin Zhang, Da‐Qiang Li, Zhi-Ming Shao, Zhi-Ming Shao
Topics & Concepts
Triple-negative breast cancerCancer researchLapatinibBreast cancerAutophagyDownregulation and upregulationBiologyCancerChemistryTrastuzumabApoptosisGeneGeneticsBiochemistryMicrotubule and mitosis dynamicsAutophagy in Disease and TherapyUbiquitin and proteasome pathways